Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 064722/0125 | |
| Pages: | 3 |
| | Recorded: | 08/28/2023 | | |
| Attorney Dkt #: | NACU:1020CIP |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
18447720
|
Filing Dt:
|
08/10/2023
|
|
Publication #:
|
|
Pub Dt:
|
11/30/2023
| | | | |
|
Title:
|
Treatment of Age-Related Macular Degeneration, Glaucoma, and Diabetic Retinopathy with N-Acetylcysteine Amide (NACA) or (2R,2R')-3,3'-Disulfanediyl BIS(2-Acetamidopropanamide)(DiNACA)
|
|
|
Assignee
|
|
|
|
|
| 306 W. 7TH STREET, STE. 310 |
| FORT WORTH, TEXAS 76102 |
|
|
Correspondence name and address
|
| |
EDWIN S. FLORES C/O CHALKER FLORES, LLP
|
| |
14841 NORTH DALLAS PARKWAY, STE. 575
|
| |
DALLAS, TX 75254
|
Search Results as of:
06/19/2024 05:40 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
